Introduction: Various phenotypes have been identified for MYH7 gene mutation-related myopathy. Here, we describe a patient with severe muscular weakness and skeletal deformity with de novo heterozygous MYH7 gene mutation.
Introduction
MYHCI (slow skeletal muscle / b-cardiac myosin heavy chain), a type of myosin heavy chain, is expressed by the MYH7 gene and presented primarily in the slow twitch type I skeletal muscle and heart muscle of the ventricle. [1] MyHCI, found in the skeletal muscle, is known to be important for maintaining normal posture. [2] Various phenotypes have been reported to be associated with MYH7 gene mutation-related myopathy, including familial hypertrophic / dilated cardiomyopathy (CMH1; MIM # 192600), Laing distal myopathy (MPD1; MIM # 160500), myosin storage myopathy (MSM; MIM # 608358), and Congenital fiber-type disproportion (CFTD; MIM # 255310). [3] [4] [5] Here, we describe a patient with severe muscular weakness and skeletal deformity with de novo heterozygous MYH7 gene mutation.
Case reports
A 33-year-old female patient visited the outpatient department of Rehabilitation Clinic for further evaluation of severe scoliosis and weakness. There were no significant abnormal findings during the perinatal period and at the time of birth; however, the development was delayed from the time of birth. She was referred to a neurologist at age 12 months. At that time, she presented muscle weakness and hypotonic posture; she was clinically diagnosed as muscular dystrophy without gene study. At age 2 years, she was able to walk alone; at age 8 years, she was unable to walk, completely dependent on a wheelchair due to gradual worsening of weakness. At the same time, there was progression of skeletal deformity and kyphoscoliosis.
At age 31 years, she developed dyspnea. she visited another neurologist for evaluation, and SMN 1del / dup test was performed under suspicion of motor neuron disease, SMA; however, no specific findings were observed.
At age 33 years, she visited our rehabilitation clinic for the treatment of dyspnea. After admission, a comprehensive reevaluation was done for systemic review. At first, physical exam, serologic test, and neurophysiologic test, including nerve conduction study (NCS) and electromyogram (EMG), were performed. On manual muscle test (MMT), she received a grade of 4 for wrist flexor, extensor muscle, finger flexor, and extensor muscle, and a grade of 1 for all other upper and lower limb muscles. Moreover, the contracture associated with weakness further progressed to the upper and lower limbs. The patient was in a state of immobilization in shoulder flexed, elbow flexed, hip/ knee flexed, and ankle plantar flexed posture, except for the wrist and finger. Kyphoscoliosis progressed severely, and the Cobb angle was 126°at the time of measurement (Fig. 1A, B) . We did not observe any abnormal signs on the upper motor neuron. Cognitive function was normal, and her family history was uneventful. She was diagnosed with esophageal hiatal hernia with abdominal CT. Nerve conduction studies showed normal findings (Table 1 ). In electromyography, short duration, small amplitude motor unit action potential (MUAP), and early recruitment patterns were observed in the involved proximal muscles, suggesting myopathy ( Table 2) .
The chromosomal microarray showed no abnormal findings. We performed the Next-generation sequencing (NGS) study on the patient. The patient was analyzed via genetic testing, using a targeted gene sequencing panel, analyzing 293 genes-5609 exons-associated with genetic neuromuscular diseases. Genomic DNA was extracted from the peripheral blood of the patient. Library preparation and target enrichment were performed using the hybridization capture method. Custom oligo design and synthesis were done by Celemics (Korea). Massively parallel sequencing was performed using 2 Â 150 bp in the paired-end mode of MiSeq platform (Illumina, San Diego, CA). Sequence reads were aligned with the Burrow-Wheeler Aligner (version 0.7.12, MEM algorithm, MEM algorithm). After duplicated reads were removed with Picard, local realignment and recalibration were performed using the Genome Analysis Tool Kit (GATK, version 3.5). Variant calling was conducted with GATK. Variants were annotated by Variant Effect Predictor and dbNSFP. Common variants with minor allele frequency ≥1% were filtered using public databases (1000 Genomes Project, Exome Variant Server, Exome Aggregation Consortium). Average coverage of depth was 100X, and 99% of target bases were covered by 10X sequence reads.
We found a heterozygous in-frame deletion variation in the patient's MYH7 gene in exon 14 (c.1498_1500del/p.Glu500del), which is a novel variation confirmed by conventional Sanger sequencing. This variant was concluded as de novo compared with the parental conventional Sanger sequencing (Fig. 2) . This variation has not been reported in the control databases, such as the 1000 Genomes Project, Exome Aggregation Consortium, gnomAD, and the dbSNP Database.
Muscle biopsy samples were taken from the vastus lateralis muscle for confirmation. Immunohistochemical and histological studies, including the electron microscopic exam, were performed. Histochemical evidence showed specific atrophy, with increase fiber size variability and increased nuclear internalization of type I fiber on muscle biopsy, consistent with congenital myopathy. On electron microscopy, we did not observe any nemaline body, centronuclear core or multi-minicore.
One month later, she received laparoscopic hiatal hernia repair and Nissen fundoplication for esophageal hiatal hernia. After the surgical treatment, dyspnea symptom disappeared.
This study received an approval from the institutional review board and the signed consent form was obtained from the patient to publish this report.
Discussion
The evidence presented above suggests that this in-frame deletion variant is the pathogenic element, based on the American College of Medical Genetics and Genomics guidelines regarding the interpretation of sequence variations. [6] MYH7 mutation was de novo (PS2), and the muscle biopsy findings were compatible with Laing muscular dystrophy (PS3). Moreover, the mutation was absent in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2). Therefore, our patient is compatible to "pathogenic". [6] According to previous studies that reported various phenotypes of MYH7 gene-related myopathy, skeletal myopathies occurred in the LMM domain of the tail domain and cardiomyopathy occurred in the head domain. [7] One interesting thing in our case was that the location of the MYH7 gene mutation was in the myosin head domain (c.1498_1500del: p.Glu500del), unlike previously reported skeletal myopathies. Moreover, 2D-echocardiography and electrocardiogram (ECG) showed no specific findings other than grade I diastolic dysfunction. These tests showed that there was no occurrence of cardiomyopathy. A recent study, like in our case, reported skeletal myopathies occurring in the head domain and cardiomyopathies in the tail domain. [8] Thus, the phenotypic variance of MYH7 gene-related myopathy is often not explained by monogenic mutation consequences. [9, 10] In limitation, only a few patients were reported regarding the phenotypes of the MYH7 gene-related myopathy. Therefore, additional reports are required to understand the diverse phenotypes of MYH7 gene-related skeletal myopathy.
In conclusion, MYH7 gene-related skeletal myopathy has been observed in a variety of spectra, and the factors determining these phenotypic variances can be the primary pathognomic gene mutation and the mechanical overloading causing myofibrillar injury. Here, we presented a rare case of de novo mutation of the myosin head domain (c.1498_1500del: p.Glu500del) in the MYH7 gene. Practitioners should consider all the various phenotypes of the MYH7 gene-related myopathy.
